Bactiguard Holding AB (publ) (BACTI-B.ST)
SEK 37.2
(-2.11%)
SEK 37.2
(-2.11%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -3.95 SEK | -161.59% |
| 2022 | -1.51 SEK | 10.12% |
| 2021 | -1.68 SEK | -47.37% |
| 2020 | -1.14 SEK | -332.65% |
| 2019 | 0.49 SEK | 208.89% |
| 2018 | -0.45 SEK | -361.07% |
| 2017 | -0.10 SEK | 87.95% |
| 2016 | -0.81 SEK | -1.25% |
| 2015 | -0.80 SEK | 78.95% |
| 2014 | -3.80 SEK | 98.88% |
| 2013 | -340.70 SEK | 91.12% |
| 2012 | -3835.90 SEK | -150.63% |
| 2011 | -1530.50 SEK | 38.16% |
| 2010 | -2475.00 SEK | -422.73% |
| 2009 | 766.90 SEK | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.13 SEK | 68.29% |
| 2024 Q1 | -0.28 SEK | 64.1% |
| 2024 Q2 | -0.41 SEK | -46.43% |
| 2023 Q4 | -0.78 SEK | -11.43% |
| 2023 FY | - SEK | -161.59% |
| 2023 Q1 | -0.63 SEK | -57.5% |
| 2023 Q2 | -1.84 SEK | -192.06% |
| 2023 Q3 | -0.70 SEK | 61.96% |
| 2022 Q3 | -0.24 SEK | 38.46% |
| 2022 Q4 | -0.40 SEK | -66.67% |
| 2022 FY | - SEK | 10.12% |
| 2022 Q1 | -0.47 SEK | 34.72% |
| 2022 Q2 | -0.39 SEK | 17.02% |
| 2021 Q1 | -0.31 SEK | 3.13% |
| 2021 Q3 | -0.31 SEK | 13.89% |
| 2021 Q4 | -0.72 SEK | -132.26% |
| 2021 FY | - SEK | -47.37% |
| 2021 Q2 | -0.36 SEK | -16.13% |
| 2020 Q2 | -0.01 SEK | 97.59% |
| 2020 Q1 | -0.34 SEK | -826.5% |
| 2020 FY | - SEK | -332.65% |
| 2020 Q3 | -0.48 SEK | -5753.66% |
| 2020 Q4 | -0.32 SEK | 33.33% |
| 2019 FY | - SEK | 208.89% |
| 2019 Q4 | 0.05 SEK | -93.41% |
| 2019 Q3 | 0.71 SEK | 517.65% |
| 2019 Q2 | -0.17 SEK | -70.0% |
| 2019 Q1 | -0.10 SEK | 41.18% |
| 2018 Q3 | -0.02 SEK | 41.7% |
| 2018 Q4 | -0.17 SEK | -975.95% |
| 2018 FY | - SEK | -361.07% |
| 2018 Q1 | -0.24 SEK | -769.57% |
| 2018 Q2 | -0.03 SEK | 88.71% |
| 2017 Q4 | -0.03 SEK | -109.09% |
| 2017 Q3 | -0.01 SEK | 92.67% |
| 2017 FY | - SEK | 87.95% |
| 2017 Q2 | -0.18 SEK | -250.0% |
| 2017 Q1 | 0.12 SEK | 154.55% |
| 2016 Q3 | -0.02 SEK | 93.13% |
| 2016 Q4 | -0.22 SEK | -1292.41% |
| 2016 Q1 | -0.34 SEK | -213.33% |
| 2016 FY | - SEK | -1.25% |
| 2016 Q2 | -0.23 SEK | 32.35% |
| 2015 Q3 | 0.20 SEK | 157.14% |
| 2015 Q1 | -0.92 SEK | -95.74% |
| 2015 FY | - SEK | 78.95% |
| 2015 Q2 | -0.35 SEK | 61.96% |
| 2015 Q4 | 0.30 SEK | 50.0% |
| 2014 Q2 | -2.04 SEK | 99.9% |
| 2014 Q4 | -0.47 SEK | 0.0% |
| 2014 FY | - SEK | 98.88% |
| 2014 Q3 | -0.47 SEK | 76.96% |
| 2014 Q1 | -1959.00 SEK | -203.54% |
| 2013 Q3 | -513.70 SEK | 62.84% |
| 2013 Q4 | 1892.10 SEK | 468.33% |
| 2013 Q1 | -336.70 SEK | -278.24% |
| 2013 Q2 | -1382.30 SEK | -310.54% |
| 2013 FY | - SEK | 91.12% |
| 2012 Q2 | -2592.10 SEK | 0.0% |
| 2012 FY | - SEK | -150.63% |
| 2012 Q4 | 188.90 SEK | 111.4% |
| 2012 Q3 | -1656.90 SEK | 36.08% |
| 2011 Q4 | - SEK | 0.0% |
| 2011 FY | - SEK | 38.16% |
| 2010 FY | - SEK | -422.73% |
| 2009 FY | - SEK | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Acarix AB (publ) | -0.16 SEK | -2368.75% |
| ADDvise Group AB (publ) | 0.56 SEK | 805.357% |
| ADDvise Group AB (publ) | 0.56 SEK | 805.357% |
| Arcoma AB | 0.19 SEK | 2178.947% |
| BICO Group AB (publ) | -12.99 SEK | 69.592% |
| Boule Diagnostics AB (publ) | 0.64 SEK | 717.188% |
| CellaVision AB (publ) | 5.46 SEK | 172.344% |
| Clinical Laserthermia Systems AB (publ) | -23.76 SEK | 83.375% |
| Chordate Medical Holding AB (publ) | -0.13 SEK | -2938.462% |
| C-Rad AB (publ) | 1.05 SEK | 476.19% |
| Duearity AB (publ) | -0.40 SEK | -887.5% |
| Dignitana AB (publ) | -0.25 SEK | -1480.0% |
| Episurf Medical AB (publ) | -0.36 SEK | -997.222% |
| Getinge AB (publ) | 8.86 SEK | 144.582% |
| Scandinavian Real Heart AB (Publ) | -0.70 SEK | -464.286% |
| Iconovo AB (publ) | -4.39 SEK | 10.023% |
| Integrum AB (publ) | 0.23 SEK | 1817.391% |
| Luxbright AB (publ) | -0.37 SEK | -967.568% |
| Mentice AB (publ) | -0.11 SEK | -3490.909% |
| OssDsign AB (publ) | -1.59 SEK | -148.428% |
| Paxman AB (publ) | 0.44 SEK | 997.727% |
| Promimic AB (publ) | -0.50 SEK | -690.0% |
| Qlife Holding AB (publ) | -526.52 SEK | 99.25% |
| SciBase Holding AB (publ) | -0.51 SEK | -674.51% |
| ScandiDos AB (publ) | -0.32 SEK | -1134.375% |
| Sectra AB (publ) | 2.22 SEK | 277.928% |
| Sedana Medical AB (publ) | -0.60 SEK | -558.333% |
| Senzime AB (publ) | -1.45 SEK | -172.414% |
| SpectraCure AB (publ) | -0.21 SEK | -1780.952% |
| Stille AB | 5.31 SEK | 174.388% |
| Vitrolife AB (publ) | -28.44 SEK | 86.111% |
| Xvivo Perfusion AB (publ) | 3.07 SEK | 228.664% |